Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
23.80
+0.76 (3.30%)
Dec 20, 2024, 4:00 PM EST - Market closed
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $704.41 million as of December 20, 2024. Its market cap has increased by 348.90% in one year.
Market Cap
704.41M
Enterprise Value
423.60M
1-Year Change
348.90%
Ranking
Category
Stock Price
$23.80
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $704.41M, an increase of 332.17%. That is a compound annual growth rate of 215.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 704.41M | 357.10% |
| Dec 29, 2023 | 154.10M | -5.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tyra Biosciences | 736.45M |
| Anavex Life Sciences | 731.79M |
| Erasca | 718.13M |
| Oculis Holding AG | 712.23M |
| Ironwood Pharmaceuticals | 712.13M |
| Kura Oncology | 700.65M |
| Tectonic Therapeutic | 699.87M |
| Bioventus | 697.47M |